Company / Gross Profit
10x Genomics, Inc. Gross Profit History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$443.9M
FY2025
5-year range
$396.0M / $443.9M
FY2021-FY2025
Trend
+7.1%
vs FY2024
Sector context
#60 of 95
Health Care
What the data says
At $444M, 10x Genomics, Inc.'s gross profit ranks #60 of 95 in the Health Care sector. Gross Profit has increased for 3 consecutive years, from $396M in FY2022 to $444M in FY2025.
Based on SEC 10-K filings.
$444M in FY2025 with a 5-year CAGR of +13.1%.
Improved from $409M to $444M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +3.9%
- 5-Year CAGR
- +13.1%
- 10-Year CAGR
- -
Sector benchmark
#60 of 95 in Health CareTop 63% of 95This company $443.9M Sector average $1.9B
▼
-76.3% below sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s gross profit has grown for 3 consecutive years.
- 5-year CAGR of +13.1%, indicating consistent growth.
- In FY2025, gross profit increased 7.1% year-over-year.
- Ranks #60 out of 95 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $443.9M | +7.1% |
| FY2024 | $414.5M | +1.3% |
| FY2023 | $409.3M | +3.4% |
| FY2022 | $396.0M | -4.9% |
| FY2021 | $416.4M | +73.2% |
| FY2020 | $240.4M | +30.0% |
| FY2019 | $184.9M | +57.1% |
| FY2018 | $117.7M | +94.4% |
| FY2017 | $60.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026